ClinicalTrials.Veeva

Menu

Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology

University Hospitals (UH) logo

University Hospitals (UH)

Status

Completed

Conditions

IUD Insertion Pain

Treatments

Device: Placebo Transcutaneous electrical nerve stimulation (TENS)
Device: Transcutaneous electrical nerve stimulation (TENS)

Study type

Interventional

Funder types

Other

Identifiers

NCT06335823
STUDY20231621

Details and patient eligibility

About

Pain with intrauterine device (IUD) insertion is very common and there are few options for patients to help reduce this pain. Transcutaneous electric nerve stimulators (TENS) are a non-invasive procedure that may help reduce the pain with IUD insertions. The investigators hope that the information gleaned from this study will result in pain control options for future patients who desire an IUD placement.

Enrollment

60 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18-45 years old
  • Individuals with a cervix and uterus
  • Seeking intrauterine device (IUD) placement for contraception or management of abnormal uterine bleeding
  • Meet medical eligibility for IUD placement
  • Ability to consent in English
  • Ability to use the visual analogue scale (VAS)

Exclusion criteria

  • Contraindications to IUD placement
  • Use of analgesics within the last 4 hours prior to IUD placement
  • Presence of a pacemaker

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups, including a placebo group

Active TENS unit
Experimental group
Description:
All patients will have the TENS unit applied: 2 pads from channel 1 will be at T10-L1 and the second set of pads will be from S2-S4; 5 minutes prior to the start of the procedure. Patients in this arm will have the TENS unit turned on to a 80 hz preset frequency with 100 mA as the pulse width.
Treatment:
Device: Transcutaneous electrical nerve stimulation (TENS)
Non-active TENS unit
Placebo Comparator group
Description:
All patients will have the TENS unit applied: 2 pads from channel 1 will be at T10-L1 and the second set of pads will be from S2-S4; 5 minutes prior to the start of the procedure. Patients will not have the TENS unit turned on.
Treatment:
Device: Placebo Transcutaneous electrical nerve stimulation (TENS)

Trial contacts and locations

1

Loading...

Central trial contact

Jean M Marino, APRN-CNP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems